Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For healthy volunteers:
- You have no history of mental health conditions or other major health problems
For patients (Cohort I – first seizure group):
- You are between 16 and 55 years old
- You have had a first seizure that strongly suggests epilepsy, but you do not yet fully meet the official diagnosis criteria for epilepsy
For patients (Cohort II – diagnosed epilepsy group):
- You are between 16 and 55 years old
- You have been officially diagnosed with epilepsy according to recognised international criteria
For patients (Cohort III – epilepsy with brain scan findings group):
- You are between 18 and 55 years old
- You have been officially diagnosed with epilepsy according to recognised international criteria
- Your MRI brain scan shows a specific area that appears to be linked to your seizures, matching your seizure pattern and/or brainwave test results
Who may not be able to join:
Healthy volunteers:
- You have a current or past neurological condition, serious physical illness, or take medications that could affect test results
- You are not fluent in Danish, or you have significant vision or hearing difficulties
- You have a current or past learning disability
- You are pregnant or breastfeeding (if female)
- You have been exposed to more than 10 millisieverts (a unit measuring radiation) in research studies in the past year, or you are regularly exposed to radiation through your work
- You have a reason you cannot have an MRI scan, such as a pacemaker or metal implants
- You have had a serious head injury
- You have a current or past problem with alcohol or drug misuse
- You have used any drugs (other than tobacco or alcohol) in the last 30 days
- You have used cannabis more than 50 times in your lifetime
- You have used any individual other substance more than 10 times in your lifetime
- You are currently taking any medication that affects mood, thinking, or mental health
Patients (all groups, Cohorts I–III):
- Your life expectancy is less than 10 years
- You have a known genetic syndrome, significant intellectual disability, or a condition that has caused major changes to your brain structure, such as a brain tumour, major stroke, or serious brain injury
- You weigh less than 40 kg (approximately 88 lbs)
- Your kidneys are not working well enough (confirm with trial site for specific kidney function levels)
- Your liver function is moderately reduced
- You have a heart rhythm or electrical condition, such as Brugada syndrome or long QT syndrome
- You take certain medications that could interfere with the study drugs or the study itself — including some seizure medicines, certain antidepressants, or other specific drugs (confirm with trial site for the full list)
- You have a reason you cannot have an MRI scan, such as a pacemaker or magnetic implants
- You are unable to complete an MRI scan or, if in Cohort III, a PET scan — for example, due to claustrophobia or severe back pain
- You have been exposed to more than 10 millisieverts of radiation in research studies in the past year, or are regularly exposed to radiation through work (Cohort III only)
- You are pregnant or breastfeeding
- You are not fluent in Danish, or you have significant vision or hearing difficulties, or a severe intellectual disability
- You have a current or past problem with alcohol or drug misuse
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lars Hageman Pinborg, MD, Neurobiological Research Unit
Phone: +45 35 45 36 43
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Categorical effect of anti-seizure medication (ASM) on treatment outcome (Cohort II-III).; Categorical effect of a second seizure/epilepsy diagnosis for patients in Cohort I.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.